Literature DB >> 19154005

Microsatellite repeat instability and neurological disease.

Judith R Brouwer1, Rob Willemsen, Ben A Oostra.   

Abstract

Over 20 unstable microsatellite repeats have been identified as the cause of neurological disease in humans. The repeat nucleotide sequences, their location within the genes, the ranges of normal and disease-causing repeat length and the clinical outcomes differ. Unstable repeats can be located in the coding or the non-coding region of a gene. Different pathogenic mechanisms that are hypothesised to underlie the diseases are discussed. Evidence is given both from studies in simple model systems and from studies on human material and in animal models. Since somatic instability might affect the clinical outcome, this is briefly touched on. Available data and theories on the timing and mechanisms of the repeat instability itself are discussed, along with factors that have been observed to affect instability. Finally, the question of why the often harmful unstable repeats have been maintained throughout evolution is addressed.

Entities:  

Mesh:

Year:  2009        PMID: 19154005      PMCID: PMC4321794          DOI: 10.1002/bies.080122

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  101 in total

1.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

Authors:  S L Sherman
Journal:  Am J Hum Genet       Date:  2000-06-12       Impact factor: 11.025

2.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions.

Authors:  Christopher E Pearson; Mandy Tam; Yuh-Hwa Wang; S Erin Montgomery; Arvin C Dar; John D Cleary; Kerrie Nichol
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

4.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Instability of CGG repeats in transgenic mice.

Authors:  Sujatha Baskaran; Sonal Datta; Arundhati Mandal; Neerja Gulati; Satish Totey; Rajesh R Anand; Vani Brahmachari
Journal:  Genomics       Date:  2002-08       Impact factor: 5.736

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.

Authors:  E Reyniers; L Vits; K De Boulle; B Van Roy; D Van Velzen; E de Graaff; A J Verkerk; H Z Jorens; J K Darby; B Oostra
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

8.  Somatic instability of CTG repeat in myotonic dystrophy.

Authors:  T Ashizawa; J R Dubel; Y Harati
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

9.  Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli.

Authors:  S Kang; A Jaworski; K Ohshima; R D Wells
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

10.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

View more
  64 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Searching for non-B DNA-forming motifs using nBMST (non-B DNA motif search tool).

Authors:  R Z Cer; K H Bruce; D E Donohue; N A Temiz; U S Mudunuri; M Yi; N Volfovsky; A Bacolla; B T Luke; J R Collins; R M Stephens
Journal:  Curr Protoc Hum Genet       Date:  2012-04

3.  PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair.

Authors:  Anna Pluciennik; Leonid Dzantiev; Ravi R Iyer; Nicoleta Constantin; Farid A Kadyrov; Paul Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

4.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

Review 5.  Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Authors:  Huiping Tan; Zihui Xu; Peng Jin
Journal:  Exp Neurol       Date:  2012-01-27       Impact factor: 5.330

6.  A dual-mode single-molecule fluorescence assay for the detection of expanded CGG repeats in Fragile X syndrome.

Authors:  Brian Cannon; Cynthia Pan; Liangjing Chen; Andrew G Hadd; Rick Russell
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

7.  Defining genetic factors that modulate intergenerational CAG repeat instability in Drosophila melanogaster.

Authors:  Joonil Jung; Marijn T M van Jaarsveld; Shin-Yi Shieh; Kexiang Xu; Nancy M Bonini
Journal:  Genetics       Date:  2010-11-01       Impact factor: 4.562

8.  A game of hide and seq: Identification of parallel Y-STR evolution in deep-rooting pedigrees.

Authors:  Sofie Claerhout; Michiel Van der Haegen; Lisa Vangeel; Maarten H D Larmuseau; Ronny Decorte
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

Review 9.  Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases.

Authors:  Giulietta Riboldi; Chiara Zanetta; Michela Ranieri; Monica Nizzardo; Chiara Simone; Francesca Magri; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Mol Neurobiol       Date:  2014-05-09       Impact factor: 5.590

Review 10.  Pathogenic mechanisms of myotonic dystrophy.

Authors:  Johanna E Lee; Thomas A Cooper
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.